Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide + Sulfonylurea in Type 2 Diabetes (Japan)
NCT00395746Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Oct 2006
- Primary completion
- Oct 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Oct 2006; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00395746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00395746.